Hollings Home  
 
Charles L Bennett, MD, PhD
Professor of Clinical Pharmacy & Outcome Sciences
College of Pharmacy
USC

Email: bennettc@sccp.sc.edu
 
       Print This Page
       
 
 


 

Charles L Bennett, MD, PhD

Return to Search Page  

Research Interest:

My research interests include the identification and dissemination of information on adverse drug reactions; costs and quality of cancer care; health policy and minority issues for cancer patients; low literacy; and cancer prevention, screening, detection, and treatment. I am the principal investigator for the independent pharmaceutical safety program, the Research on Adverse Drug Events and Reports (RADAR) project, a National Institute of Health funded program that evaluates the safety of pharmaceuticals and medical devices with annual sales of $1 billion or greater. In the past decade, RADAR has identified 38 potentially fatal and previously unrecognized adverse drug reactions. The result has been improved safety information on product labels and savings of thousands of lives. All of the identified drugs or devices continue to have robust sales, but at the same time, their safety profiles have been improved.

Honors:
Endowed Chair in Medication Safety and Efficacy, SmartState Center of Economic Excellence

Selected Publications:

1.Prasad SM, Sartor AO, Bennett CL. Editorial comment. Urology. .83(1):152-3, 2013.
View in: PubMed

2.Scott Sutton S, Stacy JJ, Mensch J, Torres-McGehee T, Bennett CL. Tackling community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in collegiate football players following implementation of an anti-MRSA programme. Br J Sports Med. ., 2013.
View in: PubMed

3.Magwood JS, Lebby A, Chen B, Kessler S, Norris L, Bennett CL. Emerging drugs for treatment of anemia of chronic kidney disease. Expert Opin Emerg Drugs. .18(4):421-9, 2013.
View in: PubMed

4.Rao GA, Mann JR, Shoaibi A, Pai SG, Bottai M, Sutton SS, Haddock KS, Bennett CL, Hebert JR. Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. .31(8):1669-75, 2013. PMCID: PMC3879726
View in: PubMed

5.Prasad SM, Bennett CL. Finishing the picture: problems with public reporting of clinical trials. J Clin Oncol. .31(24):2981-2, 2013.
View in: PubMed

6.Prasad SM, Bennett CL. Editorial comment. Urology. .82(1):66, 2013.
View in: PubMed

7.Rao GA, Mann JR, Bottai M, Uemura H, Burch JB, Bennett CL, Haddock KS, H├ębert JR. Angiotensin receptor blockers and risk of prostate cancer among United States veterans. J Clin Pharmacol. .53(7):773-8, 2013. PMCID: PMC3768141
View in: PubMed

8.Li YJ, Xirasagar S, Pumkam C, Krishnaswamy M, Bennett CL. Vision insurance, eye care visits, and vision impairment among working-age adults in the United States. JAMA Ophthalmol. .131(4):499-506, 2013.
View in: PubMed

9.Bennett CL, Jacob S, Dunn BL, Georgantopoulos P, Zheng XL, Kwaan HC, McKoy JM, Magwood JS, Qureshi ZP, Bandarenko N, Winters JL, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Ablin RJ, Rock G, Matsumoto M, Fujimura Y. Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol. .161(6):896-8, 2013. PMCID: PMC3804577
View in: PubMed

10.Bennett CL, Djulbegovic B, Norris LB, Armitage JO. Colony-stimulating factors for febrile neutropenia during cancer therapy. N Engl J Med. .368(12):1131-9, 2013.
View in: PubMed

11.Prasad SM, Bennett CL. Editorial comment. Urology. .81(1):154; author reply 154, 2013.
View in: PubMed

12.Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, Graham PL, D'Amico AV, Nguyen PL. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. .81(1):130-4, 2013.
View in: PubMed

13.Cunningham JE, Walters CA, Hill EG, Ford ME, Barker-Elamin T, Bennett CL. Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program. Breast Cancer Res Treat. .137(2):589-98, 2012. PMCID: PMC3660400
View in: PubMed

14.Li YJ, Xirasagar S, Pumkam C, Krishnaswamy M, Bennett CL. Vision Insurance, Eye Care Visits, and Vision Impairment Among Working-Age Adults in the United States. Arch Ophthalmol. .1-8, 2012.
View in: PubMed

15.Maxwell W, Bennett CL. Will newer anticoagulants improve therapy persistence? Arch Intern Med. .172(21):1689-90, 2012.
View in: PubMed

16.Kwaan HC, Bennett CL. Adverse effects of drugs on hemostasis and thrombosis. Semin Thromb Hemost. .38(8):755-8, 2012.
View in: PubMed

17.Maxwell WD, Bennett CL. Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):759-67, 2012.
View in: PubMed

18.Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Armstrong JM, Raisch DW, Bennett CL. Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):845-53, 2012. PMCID: PMC3804561
View in: PubMed

19.Bennett CL, Spiegel DM, Macdougall IC, Norris L, Qureshi ZP, Sartor O, Lai SY, Tallman MS, Raisch DW, Smith SW, Silver S, Murday AS, Armitage JO, Goldsmith D. A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):783-96, 2012.
View in: PubMed

20.Moore TJ, Bennett CL. Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. .38(8):905-7, 2012.
View in: PubMed

21.Bian J, Bennett CL, Fisher DA, Ribeiro M, Lipscomb J. Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol. .30(32):3947-52, 2012. PMCID: PMC3488268
View in: PubMed

22.Kyriacou DN, Dobrez D, Parada JP, Steinberg JM, Kahn A, Bennett CL, Schmitt BP. Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity. Biosecur Bioterror. .10(3):264-79, 2012. PMCID: PMC3440066
View in: PubMed

23.Prasad SM, Keane T, Bennett CL. Editorial comment. Urology. .80(3):563, 2012.
View in: PubMed

24.Bennett CL, Starko KM, Thomsen HS, Cowper S, Sartor O, Macdougall IC, Qureshi ZP, Bookstaver PB, Miller AD, Norris LB, Xirasagar S, Trenery A, Lopez I, Kahn A, Murday A, Luminari S, Cournoyer D, Locatelli F, Ray P, Mattison DR. Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med. .27(12):1697-703, 2012. PMCID: PMC3509314
View in: PubMed

25.Prasad SM, Keane TE, Bennett CL. Editorial comment. Urology. .80(1):168, 2012.
View in: PubMed

26.Passman RS, Bennett CL, Purpura JM, Kapur R, Johnson LN, Raisch DW, West DP, Edwards BJ, Belknap SM, Liebling DB, Fisher MJ, Samaras AT, Jones LG, Tulas KM, McKoy JM. Amiodarone-associated optic neuropathy: a critical review. Am J Med. .125(5):447-53, 2012. PMCID: PMC3322295
View in: PubMed

27.Bennett CL. A 56-year-old physician who underwent a PSA test. Arch Intern Med. .172(4):311, 2012.
View in: PubMed

28.Bennett CL, Qureshi ZP, Sartor AO, Norris LB, Murday A, Xirasagar S, Thomsen HS. Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clin Kidney J. .5(1):82-88, 2012. PMCID: PMC3341839
View in: PubMed

29.Qureshi ZP, Norris L, Sartor O, McKoy JM, Armstrong J, Raisch DW, Garg V, Stafkey-Mailey D, Bennett CL. Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States. J Oncol Pract. .8(2):84-90, 2011. PMCID: PMC3457834
View in: PubMed

30.Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. .110(2):201-5, 2011.
View in: PubMed

31.Bennett CL. Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med. .78 Suppl 2:S13-7, 2011.
View in: PubMed

32.Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL. Pharmaceutical fraud and abuse in the United States, 1996-2010. Arch Intern Med. .171(16):1503-6, 2011.
View in: PubMed

33.Felder TM, Lal LS, Bennett CL, Hung F, Franzini L. Cancer patients' use of pharmaceutical patient assistance programs in the outpatient pharmacy at a large tertiary cancer center. Community Oncol. .8(6):279-286, 2011. PMCID: PMC3413301
View in: PubMed

34.Raisch DW, Campbell W, Garg V, Qureshi ZP, Bookstaver PB, Norris LB, Bennett CL. Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication. Expert Opin Drug Saf. .10(4):521-8, 2011.
View in: PubMed

35.Qureshi ZP, Liu Y, Sartor O, Chu YH, Bennett CL. Enforcement actions involving Medicaid fraud and abuse, 1996-2009. Arch Intern Med. .171(8):785-7, 2011.
View in: PubMed

36.Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. .31(4):408-23, 2011.
View in: PubMed

37.Edwards BJ, Raisch DW, Shankaran V, McKoy JM, Gradishar W, Bunta AD, Samaras AT, Boyle SN, Bennett CL, West DP, Guise TA. Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. Clin Cancer Res. .17(3):560-8, 2011. PMCID: PMC3058419
View in: PubMed

38.Mortimer JE, Barsevick AM, Bennett CL, Berger AM, Cleeland C, DeVader SR, Escalante C, Gilreath J, Hurria A, Mendoza TR, Rugo HS. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. .8(12):1331-9, 2010.
View in: PubMed

39.Xirasagar S, Bennett CL, Hebert JR. Screening colonoscopy vs flexible sigmoidoscopy. JAMA. .304(18):2016-7; author reply 2017-8, 2010.
View in: PubMed

40.Miller AD, Piro CC, Rudisill CN, Bookstaver PB, Bair JD, Bennett CL. Nighttime and weekend medication error rates in an inpatient pediatric population. Ann Pharmacother. .44(11):1739-46, 2010.
View in: PubMed

41.Bennett CL, Lai SY, Henke M, Barnato SE, Armitage JO, Sartor O. Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents. Arch Intern Med. .170(16):1490-8, 2010.
View in: PubMed

42.Ablin RJ, Sartor O, Bennett CL. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer". Arch Intern Med. .170(15):1397-9, 2010.
View in: PubMed

43.Mayhew R, McKoy JM, Ha Luu T, Lopez I, Frick M, Bennett CL. Adverse drug interactions: moving from perception to action. Pharmacoeconomics. .28(1):19-22, 2010.
View in: PubMed

44.Richey EA, Lyons EA, Nebeker JR, Shankaran V, McKoy JM, Luu TH, Nonzee N, Trifilio S, Sartor O, Benson AB, Carson KR, Edwards BJ, Gilchrist-Scott D, Kuzel TM, Raisch DW, Tallman MS, West DP, Hirschfeld S, Grillo-Lopez AJ, Bennett CL. Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol. .27(26):4398-405, 2009. PMCID: PMC2744277
View in: PubMed

45.Simon MA, Dong X, Bennett CL. Partnering to promote equality in cancer care. Soc Work Public Health. .24(4):355-9, 2009.
View in: PubMed

46.Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. .(112):S20-4, 2009. PMCID: PMC3500614
View in: PubMed

47.McKoy JM, Bolden CR, Samaras A, Raisch DW, Chandler K, Bennett CL. Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment. Community Oncol. .6(2):78-80, 2009. PMCID: PMC2800378
View in: PubMed

48.Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. .249(1):63-71, 2009.
View in: PubMed

49.McKoy JM, Bennett CL, Scheetz MH, Differding V, Chandler KL, Scarsi KK, Yarnold PR, Sutton S, Palella F, Johnson S, Obadina E, Raisch DW, Parada JP. Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project. Drug Saf. .32(2):147-58, 2009. PMCID: PMC2768573
View in: PubMed

50.Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. .9(12):1166-72, 2008.
View in: PubMed

51.Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A, Patel JD, Kern RC, Munshi HG, Calhoun EA, Bennett CL. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. .113(6):1446-52, 2008.
View in: PubMed

52.McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, Casadevall N, Bennett CL. Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion. .48(8):1754-62, 2008. PMCID: PMC2730535
View in: PubMed

53.Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. .299(8):914-24, 2008.
View in: PubMed

54.McKoy JM, Tigue CC, Bennett CL. Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin. Cancer Treat Res. .140:235-51, 2008.
View in: PubMed

55.McKoy JM, Laumann A, Samaras A, Lacouture M, West D, Raisch D, Obadina E, Fajolu O, Reilly L, Bennett CL. Gadolinium-associated nephrogenic systemic fibrosis. Community Oncol. .5(6):325-326, 2008. PMCID: PMC2777717
View in: PubMed

56.Shankaran V, McKoy JM, Dandade N, Nonzee N, Tigue CA, Bennett CL, Denberg TD. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol. .25(33):5248-53, 2007.
View in: PubMed

57.Bennett CL, Kim B, Zakarija A, Bandarenko N, Pandey DK, Buffie CG, McKoy JM, Tevar AD, Cursio JF, Yarnold PR, Kwaan HC, De Masi D, Sarode R, Raife TJ, Kiss JE, Raisch DW, Davidson C, Sadler JE, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y. Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. .50(12):1138-43, 2007. PMCID: PMC3167088
View in: PubMed

58.Angelotta C, McKoy JM, Fisher MJ, Buffie CG, Barfi K, Ramsey G, Frohlich L, Bennett CL. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia. Vox Sang. .93(2):159-65, 2007.
View in: PubMed

59.Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. .40(3):185-92, 2007.
View in: PubMed

60.McKoy JM, Fitzner KA, Edwards BJ, Alkhatib M, Tigue CC, Nonzee NJ, Bolden CR, Bennett CL. Cost considerations in the management of cancer in the older patient. Oncology (Williston Park). .21(7):851-7; discussion 858, 860, 862 passim, 2007.
View in: PubMed

61.Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. .167(10):1041-9, 2007.
View in: PubMed

62.Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. .297(18):1992-2000, 2007.
View in: PubMed

63.Evens AM, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, Miyata S, Catsaros K, Augustyniak C, Bennett CL, Tallman MS, Variakojis D, Winter JN, Gordon LI. G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol. .137(6):545-52, 2007.
View in: PubMed

64.Bennett CL, Calhoun EA. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. .12(4):478-83, 2007.
View in: PubMed

65.Kyriacou DN, Yarnold PR, Stein AC, Schmitt BP, Soltysik RC, Nelson RR, Frerichs RR, Noskin GA, Belknap SM, Bennett CL. Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm. Chest. .131(2):489-96, 2007.
View in: PubMed

66.Bennett CL, Tigue CC, Fitzner KA. The economics of brain metastases. Cancer Treat Res. .136:23-9, 2007.
View in: PubMed

67.Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. .65(2):253-60, 2006.
View in: PubMed

68.Bassuk AG, Chen YZ, Batish SD, Nagan N, Opal P, Chance PF, Bennett CL. In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome. Neurogenetics. .8(1):45-9, 2006.
View in: PubMed

69.McKoy JM, Angelotta C, Bennett CL, Tallman MS, Wadleigh M, Evens AM, Kuzel TM, Trifilio SM, Raisch DW, Kell J, DeAngelo DJ, Giles FJ. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res. .31(5):599-604, 2006.
View in: PubMed

70.Wolf MS, Knight SJ, Lyons EA, Durazo-Arvizu R, Pickard SA, Arseven A, Arozullah A, Colella K, Ray P, Bennett CL. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. .68(1):89-93, 2006.
View in: PubMed

71.Belknap SM, Kuzel TM, Yarnold PR, Slimack N, Lyons EA, Raisch DW, Bennett CL. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project. Cancer. .106(9):2051-7, 2006.
View in: PubMed

72.Wolf MS, Bennett CL. Local perspective of the impact of the HIPAA privacy rule on research. Cancer. .106(2):474-9, 2006.
View in: PubMed

73.Kwaan HC, Bennett CL. Thrombotic thrombocytopenic purpura-2005. Semin Thromb Hemost. .31(6):611-4, 2005.
View in: PubMed

74.Wolf MS, Fitzner KA, Powell EF, McCaffrey KR, Pickard AS, McKoy JM, Lindenberg J, Schumock GT, Carson KR, Ferreira MR, Dolan NC, Bennett CL. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol. .23(34):8877-83, 2005.
View in: PubMed

75.Wolf MS, Davis TC, Arozullah A, Penn R, Arnold C, Sugar M, Bennett CL. Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care. .17(7):863-73, 2005.
View in: PubMed

76.Wolf MS, Bennett CL, Davis TC, Marin E, Arnold C. A qualitative study of literacy and patient response to HIV medication adherence questionnaires. J Health Commun. .10(6):509-17, 2005.
View in: PubMed

77.Dolan NC, Ferreira MR, Fitzgibbon ML, Davis TC, Rademaker AW, Liu D, Lee J, Wolf M, Schmitt BP, Bennett CL. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med. .28(5):479-82, 2005.
View in: PubMed

78.Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, Rusch VW. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. .79(5):1698-703, 2005.
View in: PubMed

79.Wolf MS, Rademaker A, Bennett CL, Ferreira MR, Dolan NC, Davis TC, Medio F, Liu D, Lee J, Fitzgibbon M. Development of a brief survey on colon cancer screening knowledge and attitudes among veterans. Prev Chronic Dis. .2(2):A11, 2005. PMCID: PMC1327705
View in: PubMed

80.Evens AM, Bennett CL, Luminari S. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group. Best Pract Res Clin Haematol. .18(3):481-9, 2005.
View in: PubMed

81.Carson KR, Evens AM, Bennett CL, Luminari S. Clinical characteristics of erythropoietin-associated pure red cell aplasia. Best Pract Res Clin Haematol. .18(3):467-72, 2005.
View in: PubMed

82.Bennett CL. The blue cross blue shield assessment technology review: summary of findings. Best Pract Res Clin Haematol. .18(3):423-31, 2005.
View in: PubMed

83.Bennett CL, Calhoun EA. Pharmacoeconomics of liposomal anthracycline therapy. Semin Oncol. .31(6 Suppl 13):191-5, 2004.
View in: PubMed

84.Wolf MS, Davis TC, Cross JT, Marin E, Green K, Bennett CL. Health literacy and patient knowledge in a Southern US HIV clinic. Int J STD AIDS. .15(11):747-52, 2004.
View in: PubMed

85.Dolan NC, Ferreira MR, Davis TC, Fitzgibbon ML, Rademaker A, Liu D, Schmitt BP, Gorby N, Wolf M, Bennett CL. Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol. .22(13):2617-22, 2004.
View in: PubMed

86.Calhoun EA, Fishman DA, Lurain JR, Welshman EE, Bennett CL. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians. Gynecol Oncol. .93(1):164-9, 2004.
View in: PubMed

87.Sureka A, Parada JP, Deloria-Knoll M, Chmiel JS, Phan L, Lyons TM, Ali S, Yarnold PR, Weinstein RA, Dehovitz JA, Jacobson JM, Goetz MB, Campo RE, Berland D, Bennett CL, Uphold CR. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. .18(2):99-107, 2004.
View in: PubMed

88.Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch DW, Kim B, Kwaan HC, McKoy JM, Schmitt BP, Davidson CJ, Yarnold PR, Gorelick PB, Bennett CL. Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. .35(2):533-7, 2004.
View in: PubMed

89.Kim SP, Feinglass J, Bennett CL, Lyons T, Simon C, Weinberg MN, Talamonti MS. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. .22(2):225-33, 2004.
View in: PubMed

90.Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol. .21(20):3859-66, 2003.
View in: PubMed

91.Talamonti MS, Kim SP, Yao KA, Wayne JD, Feinglass J, Bennett CL, Rao S. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. .134(4):720-7; discussion 727-9, 2003.
View in: PubMed

92.Siston AK, Knight SJ, Slimack NP, Chmiel JS, Nadler RB, Lyons TM, Kuzel TM, Moran EM, Sharifi R, Bennett CL. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. .61(1):172-8, 2003.
View in: PubMed

93.Calhoun EA, Bennett CL. Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program. Oncology (Williston Park). .17(1):109-14; discussion 119-21, 2003.
View in: PubMed

94.Golub R, Adams J, Dave S, Bennett CL. Cost-effectiveness considerations in the treatment of essential thrombocythemia. Semin Oncol. .29(3 Suppl 10):28-32, 2002.
View in: PubMed

95.Lindau ST, Tomori C, Lyons T, Langseth L, Bennett CL, Garcia P. The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol. .186(5):938-43, 2002.
View in: PubMed

96.Adams JR, Nathan DP, Bennett CL. Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy. Blood Rev. .16(1):65-7, 2002.
View in: PubMed

97.Weinberg PD, Hounshell J, Sherman LA, Godwin J, Ali S, Tomori C, Bennett CL. Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s. Ann Intern Med. .136(4):312-9, 2002.
View in: PubMed

98.Kim B, Lyons TM, Parada JP, Uphold CR, Yarnold PR, Hounshell JB, Sipler AM, Goetz MB, DeHovitz JA, Weinstein RA, Campo RE, Bennett CL. HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med. .16(9):583-9, 2001. PMCID: PMC1495267
View in: PubMed

99.Calhoun EA, Chang CH, Welshman EE, Fishman DA, Lurain JR, Bennett CL. Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist. .6(5):441-5, 2001.
View in: PubMed

100.Bennett CL, Crane JM. Quality improvement efforts in oncology: are we ready to begin? Cancer Invest. .19(1):86-95, 2001.
View in: PubMed